Free shipping on all orders over $ 500

Ivacaftor hydrate

Cat. No. M54658

All AbMole products are for research use only, cannot be used for human consumption.

Ivacaftor hydrate Structure
Synonym:

VX-770 hydrate

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

Ivacaftor hydrate is an orally active cystic fibrosis transmembrane conductance regulator (CFTR) enhancer for cystic fibrosis related studies.

Chemical Information
Molecular Weight 410.51
Formula C24H30N2O4
CAS Number 1134822-07-3
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Related CFTR Products
Ataluren

Ataluren (PTC124) is a novel, orally available small molecular CFTR-G542X nonsense allele inhibitor.

VX-770 (Ivacaftor)

VX-770 (Ivacaftor) is a first-in-class potentiator of CFTR, which targeting G551D-CFTR and F508del-CFTR with EC50 of 100 nM and 25 nM, respectively.

Lonidamine

Lonidamine (AF-1890) is a novel CFTR open channel blocker with an IC50 of 0.85 mM, which inhibits aerobic glycolysis in cancer cells. Lonidamine (AF-1890) is a hexokinase and mitochondrial pyruvate carrier inhibitor (Ki=2.5 μM).

VX-809

VX-809 is a CFTR corrector that improves CFTR processing and maturation in the cell.

CFTR(inh)-172

CFTR(inh)-172 is a voltage-independent, selective CFTR inhibitor with Ki of 300 nM, showing no effects on MDR1, ATP-sensitive K+ channels, or a series of other transporters.

  Catalog
Abmole Inhibitor Catalog




Keywords: Ivacaftor hydrate, VX-770 hydrate supplier, CFTR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.